0:55 Learning hours



mpMRI before biopsy: solving the challenge of delivery

This is a recording of Prostate Cancer UK's satellite session hosted at the BAUS Annual Conference on 29 June 2016 in Liverpool.

The results from the PROMIS trial show that mpMRI has the potential to safely reduce the number of men with a raised PSA level who go on to have a biopsy. This is likely to have a follow-on benefit in reducing the number of non-significant cancers being treated, as well as the number of men experiencing infections as a result of biopsy. In this session Prostate Cancer UK and expert panellists explored how prostate mpMRI before biopsy could be rolled out across the UK.

Read more about mpMRI and Prostate Cancer UK's plans to get mpMRI adopted by UK healthcare systems.

Watch Phil Haslam's webinar on MR Imaging in prostate cancer.

Date produced: June 2016

Date due for revision: June 2018


Chair: Roger Kirby, Professor of Urology, Medical Director, The Prostate Centre and Trustee of Prostate Cancer UK

Hashim Ahmed, MRC Clinician Scientist and Reader in Urology, UCL; Honorary Consultant Urological Surgeon, University College Hospital

Heather Blake, Director of Support and Influencing, Prostate Cancer UK

William (Bill) Cross, Consultant Urological Surgeon, Leeds Teaching Hospitals NHS Trust

Philip Haslam, Consultant Interventional and Uro-radiologist, Freeman Hospital, Newcastle upon Tyne

Sue Maughn, Clinical Advisor, Transforming Cancer Services for London; Cancer Commissioning Lead, City and Hackney CCG


Roger Kirby

Roger is one of the UK’s best known and most experienced prostate surgeons. Throughout his career he has championed advances in the diagnosis, management and treatment of prostate diseases, including robot-assisted radical prostatectomy for prostate cancer. He has also maintained a strong interest in men’s health and patient safety, introducing several initiatives in these fields. Roger has written nearly 70 books and published more than 340 scientific papers. He was chairman of the charity Prostate UK for 13 years and is Secretary of The Urology Foundation. Roger has personally raised over £3 million for these charities through
marathon running, mountain climbing, trekking and cycling challenges.

Hashim Ahmed

Hashim is an internationally renowned expert in prostate cancer diagnosis, imaging and targeted biopsy, as well as minimally invasive therapies for prostate cancer having pioneered much of the work in focal therapy. He has an extensive research portfolio with about £4 million in grant income as a principal applicant and £12 million as co-applicant. He is Co-Principal Investigator in the NIHR-HTA PROMIS trial and the UCL PICTURE trial. He has published over 150 peer-reviewed papers in areas that have led to key changes in the way we diagnose and treat men with localised prostate cancer. He is currently Director of the Surgical and Interventional Trials Unit and Director of the UCH/UCL Prostate Clinical Research Programme.

Heather Blake

Heather is responsible for leading the work of Prostate Cancer UK to ensure that men have access to the best treatments, care and support. This includes the charity’s support services and our work to improve care for men across the UK. Heather has held senior operational and strategic management roles in the NHS, most recently managing community health services in Lambeth and Southwark as part of Guys and St Thomas’ NHS Foundation Trust. Prior to joining the NHS she worked as an economist and policy adviser in the civil service and has also run her own business.

Bill Cross

Bill was appointed as a Consultant Urological Surgeon at Leeds Teaching Hospitals NHS Trust in 2008. He has a specialist interest in pelvic oncology and his current post has allowed the opportunity to focus on diseases of the prostate gland, specifically prostate cancer. Following a European Fellowship to train in robotic surgery in Sweden, he has developed the robotic radical prostatectomy programme in Leeds. Since his PhD studies, Bill has been actively involved in both clinical and laboratory research, and education. Currently he is a Trial Management Group member of the STAMPEDE and RADICALS trials, sits on the clinical/scientific advisory group of the PROPOSE study and is a member of the Prostate Cancer UK education advisory group.

Philip Haslam

Phil trained in Newcastle qualifying in 1989, he then worked in Newcastle and Nottingham before returning to Newcastle to train in Radiology. He was Lecturer in Interventional Radiology at the College of Surgeons in Dublin then was appointed as a consultant interventional and uro-radiologist in Newcastle in 1999. He has a keen interest in uro-radiology and interventional radiology with a wide experience of interventional and imaging techniques. He is the current chairman of the British Society of Urogenital Radiology and also runs an online independent review website for medical devices ‘Which Medical Device’. His current areas of interest are prostatic artery embolization, prostate MRI and tumour ablation techniques.

Sue Maughn

Sue qualified as a Diagnostic Radiographer at St George’s London in 1993. She spent 16 years in a variety of roles within radiology including managing a service. Her interest in oncology stemmed from post graduate studies in cross sectional imaging and as a Cross Sectional Superintendent. In 2009 she left the acute sector to become Essex Cancer Network Director. Since 2013 she has been clinical advisor to the transforming cancer services team for London, providing oncology and radiology expertise and support for all local and regional commissioners. More recently she has, in addition, been Cancer Commissioning Lead for City and Hackney CCG.